
Venture Capital & Emerging Companies
Viewpoints
Filter by:
Mintz Venture Watch — Volume 3: A Report on Deal Trends from Q1 and Q2 2022
August 17, 2022 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Amendment to Delaware Law Permits Exculpation of Officers in Corporate Charters
August 15, 2022 | Advisory | By Daniel A. Lerner
This advisory discusses an August 1 amendment to the Delaware General Corporation Law that limits or eliminates monetary liability arising from breach of fiduciary duty of care lawsuits for some types of corporate officers.
Is a Public Benefit Corporation Right for Your Mission-Driven Business?
July 18, 2022 | Article | By Kati P. Strzelczyk
Read an analysis of the differences between public benefit corporations and traditional corporations and issues for founders of mission-driven business to consider when deciding on a corporate structure.
MintzTech Connect Industry News: Spotlight on YUR Inc.
May 25, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
Founded by Dilan Shah in 2019, YUR fit is a leader in accessible fitness technology in the gaming space. YUR’s gamified social layer pairs with virtual and augmented reality games to allow gamers to sync health data, such as exercise, sleep, and nutrition. YUR can be used within almost any digital space, allowing gamers to use various wearables and gaming platforms for fitness tracking.
MintzTech Connect: All Things Technology — May 2022
May 25, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers stock vesting in start-up companies and how to write an executive summary for a start-up and includes a spotlight on YUR Inc., a fitness technology company targeted at the gaming community.
Six Common Contract Traps: A Field Guide
March 25, 2022 | Advisory | By Alex Civetta
Read our guide to common contract traps emerging technology companies can face when negotiating contracts with large customers that have a master services agreement, including disadvantageous terms and the omission of clauses that protect vendors.
Financing Options for Life Sciences Companies in 2022
March 21, 2022 | Blog
Public and private life science companies have multiple options available for capital-raising. Here are a few to be considered.
Mintz Venture Watch — Volume 2: A Report on Deal Trends from Q3 and Q4 2021
February 9, 2022 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
MintzTech Connect Industry News: Spotlight on Miyoko’s Creamery
December 10, 2021 | Article | By Stephen Osborn
MintzTech Connect: All Things Technology — December 2021
December 10, 2021 | Article | By Daniel DeWolf, Samuel Asher Effron
Delaware Supreme Court Upholds Advance Waiver of Statutory Appraisal Rights — Affirms Key Component of “Drag Along” Critical for M&A Exits for Venture-Backed Companies
November 23, 2021 | Alert | By Matthew Gardella, Brendan J. Chaisson
Mintz Venture Watch — Volume 1: A Report on Deal Trends from Q1 and Q2 2021
August 10, 2021 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
MintzTech Connect Industry News: Spotlight on EcoCart
August 2, 2021 | Article | By Jeremy Glaser
MintzTech Connect Industry News: Spotlight on Stavvy
August 2, 2021 | Article | By Dinesh Melwani
MintzTech Connect: All Things Technology — August 2021
August 2, 2021 | Article | By Daniel DeWolf, Samuel Asher Effron
New York City Offers Up to $20 million to Projects Selected from Life Sciences Innovation Infrastructure RFP
June 24, 2021 | Alert | By Ilse P. Johnson
SPAC Chat Ep. 5: Tempering the SPAC Hype
June 4, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
SPAC Chat Ep. 4: Litigation Update: Preparing for the Next Wave of Suits Against SPACs
April 27, 2021 | Podcast | By Jeffrey Schultz, Sahir Surmeli
MintzTech Connect Industry News: Spotlight on GroGuru, Inc.
April 27, 2021 | Article | By Jeremy Glaser
MintzTech Connect: All Things Technology — April 2021
April 27, 2021 | Article | By Daniel DeWolf, Samuel Asher Effron
Explore Other Viewpoints:
- Data Centers & Digital Infrastructure
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- DEI Legal Developments
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- EnforceMintz
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Sustainable Energy & Infrastructure
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Unified Patent Court (UPC)
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology